Dana mcclintock alladapt
WebDana Mcclintock 's Email Chief Medical Officer at Alladapt Immunotherapeutics Contact Details Email da*******@alladapt.com Get Email Address Department Other Alladapt … WebMar 28, 2024 · “The Encore study is designed to assess the long-term safety and efficacy of ADP101 in patients who are allergic to one or more of the 15 most commonly allergenic foods,” said Dana McClintock, M.D., Alladapt’s Chief Medical Officer. “As an OLE study, Encore will enroll patients who completed the Harmony Phase 1/2 study.
Dana mcclintock alladapt
Did you know?
WebGroundbreaking work at Alladapt Immunotherapeutics, Inc. continues daily and appreciate interviews like this with Ashley Dombkowski and Dana McClintock. Excited to continue to advance our efforts ... WebNov 5, 2024 · Dana McClintock Current Workplace Alladapt Immunotherapeutics Location 405 El Camino Real 611, Menlo Park, California, 94025, United States Industry …
WebHarmony remains ongoing, with OLE study intended to gain insights into long-term exposure to ADP101 in qualifying patientsMENLO PARK, Calif., March 17, 2024 (GLOBE NEWSWIRE) -- Alladapt ... WebMar 17, 2024 · MENLO PARK, Calif., March 17, 2024 (GLOBE NEWSWIRE) -- Alladapt Immunotherapeutics Inc., a private, clinical-stage biopharmaceutical company …
WebAlladapt Immunotherapeutics's key executives include Ashley Dombkowski and 11 others. Ashley Dombkowski Chief Executive Officer and Co-Founder Dana McClintock Chief Medical Officer Michael Holfinger Chief Technical Officer Jim Kirchner Vice President of Manufacturing and CMC Glenn Reicin Chief Financial Officer Amelia Milani WebJan 4, 2024 · MENLO PARK, Calif., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Alladapt Immunotherapeutics Inc., a private, clinical-stage biopharmaceutical company focused on the development of prescription therapeutics to address IgE-mediated food allergy, today announced the completion of patient enrollment in Harmony, its Phase 1/2 study of …
WebPrior to joining Alladapt, Dr. McClintock was Global Head of Innovation for Immunology, Infectious Disease and Ophthalmology at Genentech/Roche. Her responsibilities …
WebView the executive profile of Dana McClintock MD, Chief Medical Officer at Alladapt Immunotherapeutics, on Equilar ExecAtlas to see current and past work history and gain … different ways steaks are cookedWebDana McClintock, MD Chief Medical Officer Glenn Reicin Chief Financial Officer Jim Kirchner, PhD Senior Vice President of Manufacturing and CMC Amelia Milani, MBA Senior Vice President of Supply Chain and … forms of carbon in cfrpdifferent ways to add a printerWebFeb 21, 2024 · Alladapt's team includes former Genentech Inc. executive Dr. Dana McClintock as chief medical officer. Its clinical and scientific advisers include Nadeau, … forms of carbon in the atmosphereWebApr 22, 2024 · MENLO PARK, Calif., April 22, 2024 (GLOBE NEWSWIRE) -- Alladapt Immunotherapeutics Inc., a private biopharmaceutical company focused on developing novel prescription therapeutics for food allergy, today announced that the first patients have been dosed in The Harmony Study, a first-in-human Phase 1/2 clinical trial to evaluate … forms of catholicismWebJan 4, 2024 · MENLO PARK, Calif., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Alladapt Immunotherapeutics Inc., a private, clinical-stage biopharmaceutical company focused … forms of cbdcWebDr. McClintock has served as Alladapt’s Chief Medical Officer since 2024. Prior to joining Alladapt, Dr. McClintock was Global Head of Innovation for Immunology, Infectious … different ways to add parentheses